Incorporating corneal pachymetry into the management of glaucoma
Journal of Cataract & Refractive Surgery, 08/20/2009
Iester M et al. – In the Early Manifest Glaucoma Trial (EMGT) with an 11–year follow–up, CCT was a significant predictive factor for glaucoma progression in patients with higher baseline IOP but not in those with lower baseline IOP. Clinical trials such as the OHTS and EMGT cannot prove that CCT is linked to a risk for glaucoma on a biological level



